Buzzy is FDA cleared to “Control pain associated with injections, venipuncture, IV starts, cosmetic injections and the temporary relief of minor injuries (muscle or tendon aches, splinters and bee stings). Also intended to treat myofascial pain caused by trigger points, restricted motion and muscle tension.”
Studies average 56 – 88% pain reduction. In our IV trial, on average Buzzy decreased pain by 50%. The greater the fear of needles (needle phobia) the better Buzzy works. Buzzy does not eliminate pain for everyone. In studies, about 3% of people experience no relief from Buzzy.
Buzzy is contraindicated for those with a sensitivity to cold, including Raynaud’s, sickle cell disease, or CRPS.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.